Nant Capital, LLC
Insider CIK 1675758 · PBLA 10% owner · IBRX 10% owner · NH 10% owner · HLGN 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio, Inc. | C Conversion deriv | 2026-03-31 | 2026-04-02 | 0 | — | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | C Conversion | 2026-03-31 | 2026-04-02 | 4,606,596 | $5.43 | $25.01M | 251,018,873 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2026-02-22 | 2026-02-24 | 114,329 | — | $0 | 114,329 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2026-02-22 | 2026-02-24 | 114,329 | — | $0 | 29,816,081 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2026-02-22 | 2026-02-24 | 58,170 | $8.70 | $506.1K | 29,757,911 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2026-02-10 | 2026-02-12 | 274,122 | — | $0 | 548,246 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2026-02-10 | 2026-02-12 | 118,560 | $6.93 | $821.6K | 29,701,752 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2026-02-10 | 2026-02-12 | 274,122 | — | $0 | 29,820,312 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2025-02-22 | 2025-02-25 | 114,329 | — | $0 | 228,658 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2025-02-22 | 2025-02-25 | 42,071 | $3.42 | $143.9K | 29,546,190 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2025-02-22 | 2025-02-25 | 114,329 | — | $0 | 29,588,261 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other deriv | 2024-12-10 | 2024-12-12 | 0 | — | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | C Conversion deriv | 2024-12-10 | 2024-12-12 | 0 | — | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other deriv | 2024-12-10 | 2024-12-12 | 0 | $505000000.00 | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | C Conversion deriv | 2024-12-10 | 2024-12-12 | 0 | — | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | C Conversion | 2024-12-10 | 2024-12-12 | 13,475,172 | $2.28 | $30.72M | 246,412,277 | SEC↗ |
| IBRX ImmunityBio, Inc. | C Conversion | 2024-12-10 | 2024-12-12 | 103,710,088 | $1.94 | $201.20M | 232,937,105 | SEC↗ |
| PBLA Panbela Therapeutics, Inc. | P Buy deriv | 2024-11-15 | 2024-11-19 | 0 | $9150000.00 | $0 | 0 | SEC↗ |
| HLGN Heliogen, Inc. | P Buy | 2024-02-15 | 2024-02-20 | 442,298 | $1.52 | $672.3K | 442,298 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other deriv | 2023-12-29 | 2024-01-03 | 0 | $380000000.00 | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other deriv | 2023-12-29 | 2024-01-03 | 0 | $30000000.00 | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | P Buy deriv | 2023-09-11 | 2023-09-13 | 0 | $200000000.00 | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other deriv | 2023-09-11 | 2023-09-13 | 0 | — | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other deriv | 2023-09-11 | 2023-09-13 | 0 | — | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other deriv | 2023-09-11 | 2023-09-13 | 0 | — | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other deriv | 2023-09-11 | 2023-09-13 | 0 | — | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other deriv | 2023-09-11 | 2023-09-13 | 0 | — | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other | 2023-09-11 | 2023-09-13 | 129,127,017 | $1.29 | $166.57M | 129,227,017 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other | 2023-09-11 | 2023-09-13 | 32,606,985 | $1.29 | $42.06M | 32,606,985 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other | 2023-09-11 | 2023-09-13 | 47,557,934 | $1.29 | $61.35M | 47,557,934 | SEC↗ |
| HLGN Heliogen, Inc. | P Buy | 2023-09-01 | 2023-09-06 | 7,360 | $6.49 | $47.8K | 946,275 | SEC↗ |
| NH NantHealth, Inc. | P Buy | 2023-08-28 | 2023-08-30 | 537,272 | $18.61 | $10.00M | 15,921,888 | SEC↗ |
| NH NantHealth, Inc. | P Buy | 2023-08-28 | 2023-08-30 | 15,384,616 | $0.39 | $6.00M | 15,384,616 | SEC↗ |
| HLGN Heliogen, Inc. | P Buy | 2023-06-22 | 2023-06-26 | 634,251 | $0.23 | $145.9K | 32,862,027 | SEC↗ |
| HLGN Heliogen, Inc. | P Buy | 2023-06-21 | 2023-06-21 | 263,695 | $0.23 | $60.6K | 32,227,776 | SEC↗ |
| HLGN Heliogen, Inc. | P Buy | 2023-06-20 | 2023-06-21 | 62,916 | $0.23 | $14.5K | 31,964,081 | SEC↗ |
| HLGN Heliogen, Inc. | P Buy | 2023-06-16 | 2023-06-21 | 40,048 | $0.22 | $8.8K | 31,901,165 | SEC↗ |
| HLGN Heliogen, Inc. | P Buy | 2023-06-15 | 2023-06-15 | 387,612 | $0.21 | $81.4K | 31,861,117 | SEC↗ |
| HLGN Heliogen, Inc. | P Buy | 2023-06-14 | 2023-06-15 | 279,752 | $0.21 | $58.7K | 31,473,505 | SEC↗ |
| HLGN Heliogen, Inc. | P Buy | 2023-06-13 | 2023-06-15 | 1,058,542 | $0.20 | $211.7K | 31,193,753 | SEC↗ |
| HLGN Heliogen, Inc. | P Buy | 2023-06-09 | 2023-06-09 | 768,835 | $0.23 | $176.8K | 30,135,211 | SEC↗ |
| HLGN Heliogen, Inc. | P Buy | 2023-06-08 | 2023-06-09 | 1,966,263 | $0.22 | $432.6K | 29,366,376 | SEC↗ |
| HLGN Heliogen, Inc. | P Buy | 2023-06-07 | 2023-06-09 | 1,000,000 | $0.25 | $250.0K | 27,400,113 | SEC↗ |
| HLGN Heliogen, Inc. | P Buy | 2023-06-02 | 2023-06-05 | 158,355 | $0.24 | $38.0K | 26,400,113 | SEC↗ |
| HLGN Heliogen, Inc. | P Buy | 2023-06-01 | 2023-06-05 | 21,657 | $0.25 | $5.4K | 26,241,758 | SEC↗ |
| HLGN Heliogen, Inc. | P Buy | 2023-04-13 | 2023-04-17 | 7,077 | $0.25 | $1.8K | 26,220,101 | SEC↗ |
| HLGN Heliogen, Inc. | P Buy | 2023-04-12 | 2023-04-12 | 172,345 | $0.25 | $43.1K | 26,213,024 | SEC↗ |
| HLGN Heliogen, Inc. | P Buy | 2023-04-11 | 2023-04-12 | 280,219 | $0.25 | $70.1K | 26,040,679 | SEC↗ |
| HLGN Heliogen, Inc. | P Buy | 2023-04-10 | 2023-04-12 | 88,086 | $0.25 | $22.0K | 25,760,460 | SEC↗ |
| HLGN Heliogen, Inc. | P Buy | 2023-04-06 | 2023-04-10 | 641,027 | $0.25 | $160.3K | 25,672,374 | SEC↗ |
| HLGN Heliogen, Inc. | P Buy | 2023-04-05 | 2023-04-10 | 385,024 | $0.24 | $92.4K | 25,031,347 | SEC↗ |
| HLGN Heliogen, Inc. | P Buy | 2023-03-24 | 2023-03-27 | 907,677 | $0.24 | $217.8K | 2,345,714 | SEC↗ |
| HLGN Heliogen, Inc. | P Buy | 2023-03-23 | 2023-03-27 | 426,374 | $0.21 | $89.5K | 1,438,037 | SEC↗ |
| HLGN Heliogen, Inc. | A Award | 2021-12-30 | 2022-07-05 | 24,646,323 | — | $0 | 24,646,323 | SEC↗ |
| HLGN Heliogen, Inc. | A Award | 2021-12-30 | 2022-07-05 | 1,011,663 | — | $0 | 1,011,663 | SEC↗ |
| NH NantHealth, Inc. | P Buy deriv | 2021-04-27 | 2021-04-28 | 62,500,000 | $62500000.00 | $3906250.00B | 0 | SEC↗ |